Zimmer Biomet(US:ZBH) RTTNews·2025-11-05 13:27Core Viewpoint - Zimmer Biomet Holdings Inc. reaffirms its adjusted earnings and revenue growth guidance for fiscal year 2025, projecting stable performance despite previous estimates [1][2]. Financial Guidance - For fiscal 2025, the company projects adjusted earnings between $8.10 and $8.30 per share [1]. - Revenue growth is expected to be in the range of 6.7 to 7.7 percent from the previous year on a reported basis [1]. - Constant currency revenue growth is anticipated to be between 6.2 and 6.7 percent, while organic constant currency revenue growth is projected at 3.5 to 4.0 percent [1]. Analyst Expectations - Analysts expect the company to report earnings of $8.14 per share, with revenue growth estimated at 7.02 percent, reaching approximately $8.22 billion for the year [3].